Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 9;13(7):739.
doi: 10.3390/vaccines13070739.

Nuclear Factor Erythroid 2-Related Factor 2 and SARS-CoV-2 Infection Risk in COVID-19-Vaccinated Hospital Nurses

Stefano Rizza  1 , Luca Coppeta  2 , Gianluigi Ferrazza  1 , Alessandro Nucera  1 , Maria Postorino  1 , Andrea Quatrana  1 , Cristiana Ferrari  2 , Rossella Menghini  1 , Susanna Longo  1 , Andrea Magrini  2 , Massimo Federici  1
Affiliations

Nuclear Factor Erythroid 2-Related Factor 2 and SARS-CoV-2 Infection Risk in COVID-19-Vaccinated Hospital Nurses

Stefano Rizza et al. Vaccines (Basel). .

Abstract

Background/Objectives: The COVID-19 pandemic has caused sickness and death among many health care workers. However, the apparent resistance of health care workers to SARS-CoV-2 infection despite their high-risk work environment remains unclear. To investigate if inflammation and circadian disruption contribute to resistance or diminished susceptibility to the SARS-CoV-2 virus, we retrospectively evaluated a cohort of volunteer hospital nurses (VHNs). Methods: A total of 246 apparently healthy VHNs (mean age 37.4 ± 5.9 years) who had received the BNT162b2 mRNA vaccine were asked to report their sleep quality, according to the Pittsburgh Sleep Quality Index, and number of SARS-CoV-2 infections during the observational study period (from the end of December 2020 to April 2025). The expression of inflammation-associated mediators and circadian transcription factors in peripheral blood mononuclear cells, as well as sleep quality, were examined. Results: Our findings revealed no anthropometric, biochemical, or inflammation-associated parameters but demonstrated significantly greater levels of NFE2L2, also known as nuclear factor erythroid-derived 2-like 2 (NFR2), gene expression in peripheral blood mononuclear cells among VHNs who had never been infected with SARS-CoV-2 (n = 97) than in VHNs with only one (n = 119) or with two or more (n = 35) prior SARS-CoV-2 infections (p < 0.01). This result was confirmed through one-to-one propensity score matching (p < 0.01). Moreover, NRF2 gene expression was not associated with the number of COVID-19 vaccinations (p = 0.598). Finally, NRF2 gene expression was higher among participants who reported better sleep quality (p < 0.01). Conclusions: Our findings suggest possible interactions among NRF2 gene expression, protection against SARS-CoV-2 infection, and the modulation of COVID-19 vaccination efficacy.

Keywords: BNT162b2 mRNA vaccine; COVID-19; SARS-CoV-2; anti-S-RBD IgG antibody; healthcare workers; vaccine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Left panel: NFR-2 mRNA levels in different groups based on the number of SARS-CoV-2 infections. p value between bars refers to post hoc comparisons using Bonferroni’s test. Right panel: NFR-2 mRNA levels in subjects divided according to the number of COVID-19 vaccinations.
Figure 2
Figure 2
NFR-2 mRNA levels in different groups based on SARS-CoV-2 infections and COVID-19 vaccinations.
See this image and copyright information in PMC

Similar articles

  • COVID-19 Vaccines.
    [No authors listed] [No authors listed] 2025 Jul 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2025 Jul 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 33355732 Free Books & Documents. Review.
  • Antibody tests for identification of current and past infection with SARS-CoV-2.
    Fox T, Geppert J, Dinnes J, Scandrett K, Bigio J, Sulis G, Hettiarachchi D, Mathangasinghe Y, Weeratunga P, Wickramasinghe D, Bergman H, Buckley BS, Probyn K, Sguassero Y, Davenport C, Cunningham J, Dittrich S, Emperador D, Hooft L, Leeflang MM, McInnes MD, Spijker R, Struyf T, Van den Bruel A, Verbakel JY, Takwoingi Y, Taylor-Phillips S, Deeks JJ; Cochrane COVID-19 Diagnostic Test Accuracy Group. Fox T, et al. Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2. Cochrane Database Syst Rev. 2022. PMID: 36394900 Free PMC article.
  • Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T, Dooley L, Ferroni E, Al-Ansary LA, van Driel ML, Bawazeer GA, Jones MA, Hoffmann TC, Clark J, Beller EM, Glasziou PP, Conly JM. Jefferson T, et al. Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6. Cochrane Database Syst Rev. 2023. PMID: 36715243 Free PMC article.
  • Anti-SARS-CoV-2 total immunoglobulin and neutralising antibody responses in healthy blood donors throughout the COVID-19 pandemic: a longitudinal observational study.
    Gütlin Y, Albertos Torres D, Gensch A, Schlotterbeck AK, Stöger L, Heller S, Infanti L, Barut GT, Thiel V, Leuzinger K, Hirsch HH, Buser A, Egli A. Gütlin Y, et al. Swiss Med Wkly. 2024 Jul 1;154:3408. doi: 10.57187/s.3408. Swiss Med Wkly. 2024. PMID: 39137369
  • Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T, Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Leeflang MM, Spijker R, Hooft L, Emperador D, Domen J, Tans A, Janssens S, Wickramasinghe D, Lannoy V, Horn SRA, Van den Bruel A; Cochrane COVID-19 Diagnostic Test Accuracy Group. Struyf T, et al. Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
See all similar articles

References

    1. Michaels D., Wagner G.R., Ryan L. Lessons From COVID-19 for Protecting Workers in the Next Pandemic. JAMA. 2023;330:23–24. doi: 10.1001/jama.2023.8229. - DOI - PubMed
    1. WHO Keep Health Workers Safe to Keep Patients Safe. [(accessed on 17 September 2020)]. Available online: https://www.who.int/news/item/17-09-2020-keep-health-workers-safe-to-kee....
    1. Michaels D., Wagner G.R. Occupational Safety and Health Administration (OSHA) and worker safety during the COVID-19 pandemic. JAMA. 2020;324:1389–1390. doi: 10.1001/jama.2020.16343. - DOI - PubMed
    1. Moss P. The T cell immune response against SARS-CoV-2. Nat. Immunol. 2022;23:186–193. doi: 10.1038/s41590-021-01122-w. - DOI - PubMed
    1. Zhang S., Xu Y., Wu K., Wang T., Su X., Han Q., Xi Y., Zhu S., Gao Y., Wang H., et al. Improved night shift schedule related to the mortality of critically ill patients with Corona Virus Disease 2019. Sleep Med. 2020;75:354–360. doi: 10.1016/j.sleep.2020.08.010. - DOI - PMC - PubMed

LinkOut - more resources